GlaxoSmithKline LLC voluntarily recalled Ventolin HFA Inhalers on Dec. 3, 2015, after the FDA announced the Class II recall due to defective delivery systems that may not deliver sufficient propellant. The agency issued recall number D-0519-2016 for the product.
How to tell if you have it
- Brand: Ventolin
- Product: Ventolin HFA Inhaler
- NDC: 0173-0682-20
- Lot #s: 5ZP1708 (Exp. 12/2016), 5ZP1951 (Exp. 02/2017)
- Quantity: 128,704 Inhalers
The hazard
Some canisters may not contain sufficient propellant to deliver the labeled claim of 200 actuations through the end of shelf life. The FDA classified this defect as a Class II recall.
Context
GovInfoNow's records show GlaxoSmithKline LLC has 11 other recalls on record since 2012-10-08. Other recent recalls of similar products include Tivicay PD Recall (2024-05-17), GlaxoSmithKline ANORO ELLIPTA inhaler recall (2023-12-12), and GlaxoSmithKline Tivicay Tablets: Incorrect Expiration Date on Labels (2022-05-13). Other recent recalls of similar products include Shoolin Pharma Chem Sildenafil Recall (2026-08-03), Kirkman VasoCaine Spray Recall (2026-02-18), and Shoolin Pharma Chem Tadalafil Recall (2026-08-03).